Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for BeiGene Ltd.
Goto 0, 1, 2, ...5, 6, Next
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2021-09-24
Purchase		 2021-09-28
5:48 pm		 LEAP THERAPEUTICS Inc LPTX BeiGene Ltd.
10% Owner		 2,543,800 $2.85 $7,249,830 7,348,437
(Direct)		 View
2021-09-14
Sale		 2021-09-16
6:06 pm		 BeiGene Ltd. BGNE OYLER JOHN
CEO		 347,803 $28.82 $10,022,365 47,814,827
(Indirect
Direct)		 View
2021-08-31
Sale		 2021-09-02
8:40 pm		 BeiGene Ltd. BGNE OYLER JOHN
CEO		 204,358 $24.09 $4,922,921 47,814,827
(Indirect
Direct)		 View
2021-08-04
Sale		 2021-08-05
9:03 pm		 BeiGene Ltd. BGNE OYLER JOHN
CEO		 83,200 $25.97 $2,160,781 47,814,827
(Indirect
Direct)		 View
2021-08-03
Sale		 2021-08-05
9:01 pm		 BeiGene Ltd. BGNE OYLER JOHN
CEO		 41,400 $25.17 $1,041,881 47,814,827
(Indirect
Direct)		 View
2021-07-22
Sale		 2021-07-22
6:23 pm		 BeiGene Ltd. BGNE OYLER JOHN
CEO		 57,900 $23.71 $1,373,070 47,814,827
(Indirect
Direct)		 View
2021-07-20
Sale		 2021-07-22
6:21 pm		 BeiGene Ltd. BGNE OYLER JOHN
CEO		 39,600 $24.6 $974,108 47,814,827
(Indirect
Direct)		 View
2021-07-07
Sale		 2021-07-08
7:11 pm		 BeiGene Ltd. BGNE OYLER JOHN
CEO		 51,300 $24.24 $1,243,717 47,814,827
(Indirect
Direct)		 View
2021-07-06
Sale		 2021-07-08
7:09 pm		 BeiGene Ltd. BGNE OYLER JOHN
CEO		 85,000 $25.29 $2,149,295 47,815,127
(Indirect
Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2022-05-17
Exercise		 2022-05-19
4:39 pm		 N/A
N/A		 BeiGene Ltd. BGNE Wang Lai
Global Head of R & D		 999,999 $3.49 1,466,686
(Direct)		 View
2022-05-17
Exercise		 2022-05-19
4:39 pm		 N/A
2026-07-13		 BeiGene Ltd. BGNE Wang Lai
Global Head of R & D		 1,233,947 $0 1,466,686
(Direct)		 View
2022-05-17
Exercise		 2022-05-19
4:39 pm		 N/A
N/A		 BeiGene Ltd. BGNE Wang Lai
Global Head of R & D		 233,948 $2.29 1,466,686
(Direct)		 View
2022-02-28
Option Award		 2022-03-02
5:12 pm		 N/A
N/A		 BeiGene Ltd. BGNE Wang Julia Aijun
CFO		 61,750 $0 143,299
(Direct)		 View
2022-02-28
Option Award		 2022-03-02
5:10 pm		 N/A
2032-02-27		 BeiGene Ltd. BGNE Riva Alessandro
Director		 22,581 $0 22,581
(Direct)		 View
2022-02-28
Option Award		 2022-03-02
5:07 pm		 N/A
2032-02-27		 BeiGene Ltd. BGNE Dugan Margaret
Director		 22,581 $0 22,581
(Direct)		 View
2021-12-15
Option Award		 2021-12-17
5:05 pm		 N/A
N/A		 BeiGene Ltd. BGNE Wang Lai
Global Head of R & D		 0 $30.13 174,551
(Indirect)		 View
2021-12-15
Gift		 2021-12-17
5:05 pm		 N/A
N/A		 BeiGene Ltd. BGNE Wang Lai
Global Head of R & D		 116,376 $0 174,551
(Direct)		 View
2021-12-15
Option Award		 2021-12-17
5:03 pm		 N/A
N/A		 BeiGene Ltd. BGNE Wu Xiaobin
COO		 0 $30.13 968,261
(Indirect)		 View
2021-12-14
Exercise		 2021-12-16
5:50 pm		 N/A
N/A		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 1,500 $119.96 371,331
(Direct)		 View
2021-12-14
Exercise		 2021-12-16
5:50 pm		 N/A
2029-06-04		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 19,500 $0 371,331
(Direct)		 View
2021-11-30
Option Award		 2021-12-02
6:21 pm		 N/A
N/A		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 15,869 $0 0
(Direct)		 View
2021-11-17
Exercise		 2021-11-19
6:18 pm		 N/A
N/A		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 1,500 $119.96 376,011
(Direct)		 View
2021-11-17
Exercise		 2021-11-19
6:18 pm		 N/A
2029-06-04		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 19,500 $0 376,011
(Direct)		 View
2021-10-19
Exercise		 2021-10-21
5:37 pm		 N/A
N/A		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 1,500 $119.96 395,511
(Direct)		 View
2021-10-19
Exercise		 2021-10-21
5:37 pm		 N/A
2029-06-04		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 19,500 $0 395,511
(Direct)		 View
2021-09-20
Exercise		 2021-09-22
6:15 pm		 N/A
N/A		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 6,000 $119.96 415,011
(Direct)		 View
2021-09-20
Exercise		 2021-09-22
6:15 pm		 N/A
2029-06-04		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 78,000 $0 415,011
(Direct)		 View
2021-08-31
Option Award		 2021-09-02
8:39 pm		 N/A
N/A		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 15,374 $0 0
(Direct)		 View
2021-07-15
Exercise		 2021-07-19
4:43 pm		 N/A
N/A		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 6,914 $160.4 974,206
(Direct)		 View
2021-07-15
Exercise		 2021-07-19
4:43 pm		 N/A
N/A		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 8,831 $119.96 974,206
(Direct)		 View
2021-07-15
Exercise		 2021-07-19
4:43 pm		 N/A
N/A		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 5,255 $174.43 974,206
(Direct)		 View
2021-07-15
Exercise		 2021-07-19
4:43 pm		 N/A
2028-06-25		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 273,000 $0 974,206
(Direct)		 View
2021-06-30
Ownership		 2021-07-01
4:55 pm		 N/A
N/A		 BeiGene Ltd. BGNE Wang Julia Aijun
CFO		 0 $0 366,483
(Direct)		 View
2021-06-28
Exercise		 2021-06-30
4:49 pm		 N/A
N/A		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 1,500 $29.49 506,236
(Direct)		 View
2021-06-28
Exercise		 2021-06-30
4:49 pm		 N/A
2026-09-02		 BeiGene Ltd. BGNE Huang Jane
CMO Hematology		 19,500 $0 506,236
(Direct)		 View
2021-06-16
Option Award		 2021-06-24
12:26 pm		 N/A
2031-06-15		 BeiGene Ltd. BGNE Yi Qingqing
Director		 25,298 $0 25,298
(Direct)		 View
2021-06-16
Option Award		 2021-06-21
4:57 pm		 N/A
2031-06-15		 BeiGene Ltd. BGNE OYLER JOHN
CEO		 1,053,156 $0 55,658,639
(Direct)		 View
2021-06-16
Option Award		 2021-06-21
4:50 pm		 N/A
2031-06-15		 BeiGene Ltd. BGNE Wang Xiaodong
Chairman		 280,839 $0 11,699,072
(Direct)		 View
Goto 0, 1, 2, ...5, 6, Next